{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:44:03Z","timestamp":1790963043727,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2020.06.082","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T03:05:38Z","timestamp":1593745538000},"page":"5240-5250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["A global agenda for older adult immunization in the COVID-19 era: A roadmap for action"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9807-2544","authenticated-orcid":false,"given":"Lois A.","family":"Privor-Dumm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Durrheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Deloria Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prarthana","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-8255","authenticated-orcid":false,"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Bonveh\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.082_b0005","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4161\/21645515.2014.982998","article-title":"Adult vaccination: Now is the time to realize an unfulfilled potential","volume":"11","author":"Tan","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.06.082_b0010","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1016\/j.vaccine.2017.07.100","article-title":"Focusing on the implementation of 21st century vaccines for adults","volume":"36","author":"Bonanni","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s41999-018-0040-8","article-title":"Vaccination programs for older adults in an era of demographic change","volume":"9","author":"Doherty","year":"2018","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0020","unstructured":"United Nations department of economic and social affairs population division. World Population Prospects 2019: Highlights; 2019."},{"key":"10.1016\/j.vaccine.2020.06.082_b0025","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","article-title":"The World report on ageing and health: a policy framework for healthy ageing","volume":"387","author":"Beard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0030","unstructured":"Institute of Medicine (US). Ethical issues in pandemic planning and response. Ethical and legal considerations in mitigating pandemic disease: workshop summary. Washington (DC); 2007."},{"key":"10.1016\/j.vaccine.2020.06.082_b0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0140-6736(07)61579-7","article-title":"Generation of political priority for global health initiatives: a framework and case study of maternal mortality","volume":"370","author":"Shiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0040","unstructured":"Coalition for epidemic preparedness innovations. CEPI expands investment in COVID-19 vaccine development. Oslo, Norway2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0045","unstructured":"Novel coronavirus pneumonia emergency response epidemiology team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. China CDC Weekly. 2020;41:145\u201351."},{"key":"10.1016\/j.vaccine.2020.06.082_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.vaccine.2020.06.082_b0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0065","unstructured":"Centers for Disease Control and Prevention. Weekly U.S. Influenza Surveillance Report; 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0070","series-title":"Global burden of disease collaborative network. Global Burden of Disease Study 2017 (GBD 2017) Cause-Specific Mortality 1980-2017","year":"2018"},{"key":"10.1016\/j.vaccine.2020.06.082_b0075","unstructured":"Centers for Disease Control & Prevention. Pneumococcal Vaccines (PCV13 and PPSV23): Addressing Common Questions about Pneumococcal Vaccination for Adults. 2019."},{"key":"10.1016\/j.vaccine.2020.06.082_b0080","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.06.082_b0085","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1086\/522152","article-title":"The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine","volume":"197","author":"Schmader","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.082_b0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.082_b0095","first-page":"245","article-title":"Influenza and pneumococcal immunization in cardiovascular prevention","volume":"74","author":"Sosa Liprandi","year":"2014","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.vaccine.2020.06.082_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181565","article-title":"A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events","volume":"12","author":"Erskine","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.082_b0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40266-016-0389-7","article-title":"An algorithm for neuropathic pain management in older people","volume":"33","author":"Pickering","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.vaccine.2020.06.082_b0115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1532-5415.2004.52205.x","article-title":"Infections and functional impairment in nursing home residents: a reciprocal relationship","volume":"52","author":"Bula","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2020.06.082_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2016.00041","article-title":"T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines","volume":"7","author":"McElhaney","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.06.082_b0125","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.vaccine.2011.04.077","article-title":"Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults","volume":"29","author":"Yao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7748\/ns.29.38.50.e9925","article-title":"Improving surgical outcomes for people with dementia","volume":"29","author":"Loughlin","year":"2015","journal-title":"Nurs Stand"},{"key":"10.1016\/j.vaccine.2020.06.082_b0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2015.12.005","article-title":"The risk of new onset depression in association with influenza\u2013A population-based observational study","volume":"53","author":"Bornand","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2020.06.082_b0140","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2468-2667(19)30019-2","article-title":"Measuring population ageing: an analysis of the global burden of disease study 2017","volume":"4","author":"Chang","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2020.06.082_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186903","article-title":"The full benefits of adult pneumococcal vaccination: A systematic review","volume":"12","author":"Cafiero-Fonseca","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.082_b0150","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2012.07.025","article-title":"Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization","volume":"30","author":"Thomas-Crusells","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14760584.2018.1471989","article-title":"Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.06.082_b0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1473-3099(13)70046-X","article-title":"AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial","volume":"13","author":"McElhaney","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.082_b0165","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0170","doi-asserted-by":"crossref","DOI":"10.3402\/jmahp.v3.26962","article-title":"The societal role of lifelong vaccination","author":"Postma","year":"2015","journal-title":"J Mark Access Health Policy"},{"key":"10.1016\/j.vaccine.2020.06.082_b0175","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2020.06.082_b0180","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","article-title":"The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults","volume":"23","author":"Schmader","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.vaccine.2020.06.082_b0185","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1016\/j.vaccine.2016.09.039","article-title":"Equity in disease prevention: Vaccines for the older adults - a national workshop, Australia 2014","volume":"34","author":"Raina MacIntyre","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12916-015-0446-9","article-title":"The broader economic impact of vaccination: reviewing and appraising the strength of evidence","volume":"13","author":"Jit","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0195","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook 10th Edition. . Canberra: Australian Government Department of Health,; 2017."},{"key":"10.1016\/j.vaccine.2020.06.082_b0200","unstructured":"Government of Canada. Public Funding for Influenza Vaccination by Province\/Territory (as of September 2017). 2017."},{"key":"10.1016\/j.vaccine.2020.06.082_b0205","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations in the U.S","volume":"49","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0210","unstructured":"Astra Zeneca. AstraZeneca takes next steps towards broad and equitable access to Oxford University\u2019s COVID-19 vaccine; 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0215","unstructured":"US department of health and human services. Trump administration\u2019s operation warp speed accelerates astrazeneca COVID-19 vaccine to be available beginning in October. 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0220","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally\u2013a review","volume":"31","author":"Peasah","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0225","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.vaccine.2017.02.044","article-title":"Systematic review of the cost-effectiveness of influenza immunization programs","volume":"35","author":"Ting","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0230","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1016\/j.vaccine.2018.08.084","article-title":"Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia","volume":"36","author":"Chen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/13696998.2018.1465272","article-title":"A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan","volume":"21","author":"Jiang","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2020.06.082_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192640","article-title":"Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands","volume":"13","author":"Thorrington","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.082_b0245","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1080\/21645515.2018.1428507","article-title":"Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium","volume":"14","author":"Willem","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.06.082_b0250","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/M18-2347","article-title":"A cost-effectiveness analysis of vaccination for prevention of herpes zoster and related complications: input for national recommendations","volume":"170","author":"Prosser","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"Melegaro","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40273-018-0735-1","article-title":"Cost-effectiveness of herpes zoster vaccination: a systematic review","volume":"37","author":"Chiyaka","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2020.06.082_b0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vaccine.2018.11.056","article-title":"Cost-effectiveness of adult vaccinations: A systematic review","volume":"37","author":"Leidner","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0270","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2020.06.082_b0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10935-015-0394-3","article-title":"Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013","volume":"36","author":"McLaughlin","year":"2015","journal-title":"J Prim Prev"},{"key":"10.1016\/j.vaccine.2020.06.082_b0280","article-title":"Remy V. The intangible benefits of vaccination - what is the true economic value of vaccination? J Mark Access","author":"Bonanni","year":"20153","journal-title":"Health Policy"},{"key":"10.1016\/j.vaccine.2020.06.082_b0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/d41586-017-08323-0","article-title":"Deploy vaccines to fight superbugs","volume":"552","author":"Rappuoli","year":"2017","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.06.082_b0290","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/j.vaccine.2016.12.001","article-title":"Moving beyond traditional valuation of vaccination: Needs and opportunities","volume":"35","author":"Bloom","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12916-016-0697-0","article-title":"Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia","volume":"14","author":"Verguet","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0300","unstructured":"United Nations. Coronavirus update: COVID-19 likely to cost economy $1 trillion during 2020, says UN trade agency. In: News U, editor; 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2471\/BLT.17.199588","article-title":"Pandemic risk: how large are the expected losses?","volume":"96","author":"Fan","year":"2018","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.06.082_b0310","year":"2016","journal-title":"Washington (DC): National Academy of Medicine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30110-8","article-title":"COVID-19 in Italy: momentous decisions and many uncertainties","author":"Lazzerini","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.06.082_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0325","unstructured":"World Bank. Global economic prospects. Washington, DC; 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0330","unstructured":"In: Feng E, editor. Weekend Addition Saturday: NPR."},{"key":"10.1016\/j.vaccine.2020.06.082_b0335","first-page":"e1","article-title":"Straining the system: novel coronavirus (COVID-19) and preparedness for concomitant disasters","author":"Smith","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2020.06.082_b0340","unstructured":"World Health Organization. Developing together the vision and strategy for immunization \u2013 2021-2030. Immunization Agenda 2030. A global strategy to leave no one behind. 2019. Draft 1. Geneva2019."},{"key":"10.1016\/j.vaccine.2020.06.082_b0345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/spid.2002.122997","article-title":"The Japanese program of vaccination of schoolchildren against influenza: implications for control of the disease","volume":"13","author":"Reichert","year":"2002","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.082_b0350","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.06.082_b0355","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","article-title":"Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature","volume":"35","author":"Tsaban","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0360","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.06.082_b0365","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ajpath.2014.08.030","article-title":"The role of viral, host, and secondary bacterial factors in influenza pathogenesis","volume":"185","author":"Kash","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2020.06.082_b0370","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/605087","article-title":"The effect of universal influenza immunization on antibiotic prescriptions: an ecological study","volume":"49","author":"Kwong","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.082_b0375","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.06.082_b0380","first-page":"1","article-title":"Update related to the current outbreak of COVID-19","author":"Gabutti","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2020.06.082_b0385","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.06.082_b0390","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of co-infection between SARS-CoV-2 and other respiratory pathogens","author":"Kim","year":"2020","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.vaccine.2020.06.082_b0395","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1016\/j.vaccine.2020.04.027","article-title":"Archetype analysis of older adult immunization decision-making and implementation in 34 countries","volume":"38","author":"Privor-Dumm","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0400","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.vaccine.2016.07.045","article-title":"A global review of national influenza immunization policies: Analysis of the 2014 WHO\/UNICEF Joint Reporting Form on immunization","volume":"34","author":"Ortiz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0405","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1016\/j.vaccine.2019.08.060","article-title":"Pharmacist role in vaccination: Evidence and challenges","volume":"37","author":"Poudel","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0410","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14760584.2018.1527690","article-title":"Life-course immunization as a gateway to health","volume":"17","author":"Philip","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.06.082_b0415","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Hesitancy SWGoV. Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0420","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.vaccine.2017.04.056","volume":"35","author":"Hickler","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2372732215600716","article-title":"Using behavioral insights to increase vaccination policy effectiveness","volume":"2","author":"Betsch","year":"2015","journal-title":"Policy Insights from the Behavioral and Brain Sciences"},{"key":"10.1016\/j.vaccine.2020.06.082_b0430","unstructured":"World Health Organization. Ten threats to global health in 2019; 2019."},{"key":"10.1016\/j.vaccine.2020.06.082_b0435","first-page":"1","article-title":"Adult vaccination in India: status and the way forward","author":"Lahariya","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.06.082_b0440","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(20)30374-3","article-title":"Technical Advisory Group for Infectious H. COVID- 19: what is next for public health?","volume":"395","author":"Heymann","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.082_b0445","unstructured":"Commonwealth of Australia Department of Health. National Immunisation Strategy for Australia 2019 to 2024; 2018."},{"key":"10.1016\/j.vaccine.2020.06.082_b0450","unstructured":"European centre for disease prevention and control. Designing and implementing an immunisation information system. Stockholm; 2018."},{"key":"10.1016\/j.vaccine.2020.06.082_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102743","article-title":"Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development","author":"Kim","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2020.06.082_b0460","unstructured":"World Health Organization. Global strategy and action plan on ageing and health. Geneva; 2017."},{"key":"10.1016\/j.vaccine.2020.06.082_b0465","unstructured":"The World Health Organization. The decade of healthy ageing 2020-2030; 2020."},{"key":"10.1016\/j.vaccine.2020.06.082_b0475","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4161\/hv.6.12.13076","article-title":"A policy framework for accelerating adoption of new vaccines","volume":"6","author":"Levine","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.06.082_b0480","doi-asserted-by":"crossref","unstructured":"Sauer M, Vasudevan P, Meghani A, Luthra K, Garcia C, Knoll M, et al. Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries 2020. Manuscript under review.","DOI":"10.1016\/j.vaccine.2021.01.066"},{"key":"10.1016\/j.vaccine.2020.06.082_b0485","first-page":"1777","article-title":"Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)","volume":"12","author":"Esposito","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.06.082_b0490","article-title":"Adult vaccination: a key component of healthy ageing","author":"Gaurau","year":"2013","journal-title":"The benefits of life-course immunisation Europe"},{"key":"10.1016\/j.vaccine.2020.06.082_b0495","unstructured":"National Vaccine Program Office. National Adult Immunization Plan 2016-2020. Washington D.C.2016."},{"key":"10.1016\/j.vaccine.2020.06.082_b0500","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.vaccine.2017.12.029","article-title":"Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22\u201323 March 2017","volume":"36","author":"Teresa Aguado","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:31Z","timestamp":1759402771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20308859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":99,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X20308859"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A global agenda for older adult immunization in the COVID-19 era: A roadmap for action","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}